Streptomyces aureofaciens Duggar (ATCC® 13191)

Strain Designations: E504  /  Type Strain: no  /  Biosafety Level: 1

Permits And Restrictions

View Permits

Strain Designations E504
Produces 5-alpha(11-alpha)-dehydrotetracycline
Produces 6-demethyltetracycline
Produces 7-chloro-6-demethyltetracycline
Produces chlortetracycline aureomycin
Produces tetracyclines
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain no
Medium ATCC® Medium 1877: ISP Medium 1
ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26°C
Atmosphere: Aerobic
Name of Depositor American Cyanamid Co.
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.

Miller PA, McCormick JR. Biological transformation of anhydrotetracycline to 5alpha(11alpha)-dehydrotetracyclines. US Patent 2,952,587 dated Sep 13 1960

McCormick JR, et al. Process of producing an antibiotic of the tetracycline series. US Patent 2,970,947 dated Feb 7 1961

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation